Rheumatology Publications

Internal Medicine

Overbury RS, Radic M (2021). Capillaroscopy as a diagnostic tool in a mixed connective tissue disease (MCTD): a case report. BMC Rheumatol, 5(9).
Acharya NR, Ebert CD, Kelly NK, Porco TC, Ramanan AV, Arnold BF, the ADJUST research group (2020). Discontinuing adalimumab in patients with controlled juvenile idiopathic arthritis - associated uveitis (ADJUST - adalimumab in juvenile idiopathic arthritis - associated uveitis stopping trial): study protocol for a randomized controlled trial. Trials, 21(887).
Overbury RS, Pritchett Q, Lebiedz-Odrobina D, Thomas JK, Braaten TJ, Clardy SL, Elgort MG, Spivak ES, Slev P, Peteson LK, Frech TM (). Assessing Cytokine Profiles and COVID-19 Serology in Patients on Immunosuppression to Guide Care Recommendations [Abstract].
Overbury RS, Frech TM, Bohnsack J, Inman CJ, Stern S, Treemarki E, Hersh AO (Fall 2020). Patient and Parent Perspectives in an Academic Pediatric Rheumatology Transition Clinic [Abstract].
Overbury RS, Frech TM, Bohnsack J, Inman CJ, Stern S, James K, Treemarki E, Hersh AO (Fall 2020). Implementation of an Evidence-Based Transition Clinic in a Pediatric Rheumatology Academic Institution [Abstract].
Overbury RS, Pupaibool J, Hansen CB, Lebiedz-Odrobina D (Fall 2020). Hydroxychloroquine Prescribing Habits and Provider Opinion on Dosing Guidelines in the Rheumatology and Dermatology Practices of an Academic Institution [Abstract].
Walsh JA, Pei S, Penmetsa GK, Overbury RS, Clegg DO, Sauer BC (2020). Identifying axial spondyloarthritis patients in large datasets: expanding possibilities for observational research. The Journal of Rheumatology, 47(12).
Overbury RS, Stoddard G, Frech TM (Fall 2020). The COVID-19 Pandemic and its Effect on Patients with Chronic Rheumatologic Disease Regarding the Value of Vaccination Recommendations [Abstract].
Belman S, Walsh JA, Carroll C, Milliken M, Haaland B, Duffin KC, Krueger GG, Feng BJ (2021). Psoriasis Characteristics for the Early Detection of Psoriatic Arthritis. J Rheumatol, 48(10), 1559-1565.
Thomas, Julie Kallikkadan (2021). The Fight of His Life [Web]. Pulses Voices from the Heart of Medicine.
Ogdie A, Walsh JA, Chakravarty SD, Peterson S, Lo KH, Kim L, Li N, Hsia EC, Chan EKH, Kavanaugh A, Husni ME (2021). The effect of intravenous golimumab on health-related quality of life and work productivity in patients with active psoriatic arthritis: results of the Phase 3 GO-VIBRANT trial. Clin Rheumatol, 40(9), 3667-3677.
Orbai AM, Reddy SM, Dennis N, Villacorta R, Peterson S, Mesana L, Chakravarty SD, Lin I, Karyekar CS, Wang Y, Pacou M, Walsh J (2021). Work absenteeism and disability associated with psoriasis and psoriatic arthritis in the USA-a retrospective study of claims data from 2009 TO 2020. (Epub ahead of print) Clin Rheumatol.
Radic M, Thomas J, McMillan S, Frech T (2021). Does sublingual microscopy correlate with nailfold videocapillaroscopy in systemic sclerosis? Clin Rheumatol, 40(6), 2263-2266.
Doubelt I, Cuthbertson D, Carette S, Chung SA, Forbess LJ, Khalidi NA, Koening CL, Langford C, McAlear CA, Moreland LW, Monach PA, Seo P, Specks U, Spiera RF, Springer JM, Sreih AG, Warrington KJ, Merkel PA, Pagnoux C, Vasculitis Clinical Research Consortium (2021). Clinical Manifestations and Long-Term Outcomes of Eosinophilic Granulomatosis With Polyangiitis in North America. (Epub ahead of print) ACR Open Rheumatol.
Wan MT, Walsh JA, Craig ET, Husni ME, Scher JU, Reddy SM, Leung YY, Ogdie A (2020). A comparison of physical function instruments in psoriatic arthritis: HAQ-DI vs MDHAQ vs PROMIS10 global physical health. Rheumatology (Oxford), 60(5), 2307-2316.
Van Tiem JM, Steffen MJ, Seaman AT, Miller KL, Wardyn SE, Richards CC, Solimeo, S (2021). Attitudes toward bone health among rural‐dwelling veterans identified as at risk of fracture: a qualitative analysis. JBMR Plus e10501, 16(1), 61.
Walsh JA, Cai Q, Lin I, Pericone CD, Chakravarty SD (2021). Treatment Persistence and Adherence Among Patients With Psoriatic Arthritis Who Initiated Targeted Immune Modulators in the US: A Retrospective Cohort Study. Adv Ther, 38(5), 2353-2364.
Walsh JA, Pei S, Penmetsa GK, Overbury RS, Clegg DO, Sauer BC (2020). Identifying Patients With Axial Spondyloarthritis in Large Datasets: Expanding Possibilities for Observational Research. J Rheumatol, 48(5), 685-692.
Mustapha N, Barra L, Carette S, Cuthbertson D, Khalidi NA, Koening CL, Langford CA, McAlear CA, Milman N, Moreland LW, Monach PA, Seo P, Specks U, Sreih AG, Ytterberg SY, Merkel PA, Pagnoux C, Canadian Vasculitis Research Network CanVasc and Vasculitis Clinical Research Consortium VCRC (2020). Efficacy of leflunomide in the treatment of vasculitis. Clin Exp Rheumatol, 39 Suppl 129(2), 114-118.
Schnappauf O, Sampaio Moura N, Aksentijevich I, Stoffels M, Ombrello AK, Hoffmann P, Barron K, Remmers EF, Hershfield M, Kelly SJ, NISC Comparative Sequencing Program, Cuthbertson D, Carette S, Chung SA, Forbess L, Khalidi NA, Koening CL, Langford CA, McAlear CA, Monach PA, Moreland L, Pagnoux C, Seo P, Springer JM, Sreih AG, Warrington KJ, Ytterberg SR, Kastner DL, Grayson PC, Merkel PA, Vasculitis Clinical Research Consortium (2021). Sequence-Based Screening of Patients With Idiopathic Polyarteritis Nodosa, Granulomatosis With Polyangiitis, and Microscopic Polyangiitis for Deleterious Genetic Variants in ADA2. Arthritis Rheumatol, 73(3), 512-519.
Miller KL, Steffen MJ, McCoy KD, Cannon G, Seaman AT, Anderson ZL, Patel S, Green J, Wardyn S, Solimeo SL (2021). Delivering fracture prevention services to rural US veterans through telemedicine: a process evaluation. Arch Osteoporos, 16(1), 27.
Thomas JK, Radic M, Tucker JR, Overbury R, Frech TM (2020). Raynaud Phenomenon in Systemic Sclerosis: Does Digital Thermal Monitoring Correlate to Specific Nailfold Videocapillaroscopy Abnormalities? J Rheumatol, 48(2), 247-250.
Kiltz U, Wei JC, van der Heijde D, van den Bosch F, Walsh JA, Boonen A, Gensler LS, Hunter T, Carlier H, Dong Y, Li X, Bolce R, Strand V, Braun J (2020). Ixekizumab Improves Functioning and Health in the Treatment of Radiographic Axial Spondyloarthritis: Week 52 Results from 2 Pivotal Studies. J Rheumatol, 48(2), 188-197.
Radic M, Thomas J, McMillan S, Frech T (2021). Does sublingual microscopy correlate with nailfold videocapillaroscopy in systemic sclerosis? (Epub ahead of print) Clin Rheumatol.
Pearson M, Barker AM, Battistone MJ, Bent S, Odden K, OBrien B (2020). Implementing an established musculoskeletal educational curriculum in a new context: a study of effectiveness and feasibility. Medical Education Online, 25(1), 1760466.
Mustapha N, Barra L, Carette S, Cuthbertson D, Khalidi NA, Koening CL, Langford CA, McAlear CA, Milman N, Moreland LW, Monach PA, Seo P, Specks U, Sreih AG, Ytterberg SY, Merkel PA, Pagnoux C, Canadian Vasculitis Research Network CanVasc and Vasculitis Clinical Research Consortium VCRC (2020). Efficacy of leflunomide in the treatment of vasculitis. (Epub ahead of print) Clin Exp Rheumatol.
Kermani T, Cuthbertson D, Carette S, Khalidi N, Koening C, Langford C, McAlear C, Monach P, Moreland L, Pagnoux C, Seo P, Specks U, Sreih A, Warrington K, Merkel P (2020). Thyroid Disease in Patients with ANCA-Associated Vasculitis [Abstract]. 72(suppl 10).
Kermani T, Cuthbertson D, Carette S, Khalidi N, Koening C, Langford C, McAlear C, Monach P, Moreland L, Pagnoux C, Seo P, Specks U, Sreih A, Warrington K, Merkel P (2020). Prevalence of Thyroid Disease Among Patients with Vasculitis [Abstract]. 72(suppl 10).
Magrey MN, Danve AS, Ermann J, Walsh JA (2020). Recognizing Axial Spondyloarthritis: A Guide for Primary Care. Mayo Clin Proc, 95(11), 2499-2508.
Gribbons KB, Ponte C, Carette S, Craven A, Cuthbertson D, Hoffman GS, Khalidi NA, Koening CL, Langford CA, Maksimowicz-McKinnon K, McAlear CA, Monach PA, Moreland LW, Pagnoux C, Quinn KA, Robson JC, Seo P, Sreih AG, Suppiah R, Warrington KJ, Ytterberg SR, Luqmani R, Watts R, Merkel PA, Grayson PC (2019). Patterns of Arterial Disease in Takayasu Arteritis and Giant Cell Arteritis. Arthritis Care Res (Hoboken), 72(11), 1615-1624.
Frech T, Ou Z, Thomas J, Presson A (2020). Clinical Bedside Tools to Assess Systemic Sclerosis Vasculopathy: Can Digital Thermal Monitoring and Sublingual Microscopy Identify Patients with Current or past Digital Ulcers? [Abstract]. 2020(72).
Thomas J, Lebiedz-Odrobina D, Register K, Ferrara F, Barlow D, Riddle A, Miller K (2020). Lessons Learned Through Rapid Quality Improvement for Telehealth Implementation in an Academic Rheumatology Practice During the COVID-19 Pandemic [Abstract]. 2020(72).
Walsh JA, Magrey M (2020). Clinical Manifestations and Diagnosis of Axial Spondyloarthritis. (Epub ahead of print) J Clin Rheumatol.
Walsh JA, Magrey MN, Baraliakos X, Inui K, Weng MY, Lubrano E, van der Heijde D, Boonen A, Gensler LS, Strand V, Braun J, Hunter T, Li X, Zhu B, Len L, Marcelino Sandoval Calderon D, Kiltz U (2020). Ixekizumab Improves Functioning and Health in the Treatment of Active Non-Radiographic Axial Spondyloarthritis: 52-Week Results, COAST-X Trial. (Epub ahead of print) Arthritis Care Res (Hoboken).
Pritchett Q, Overbury R, Lebiedz-Odrobina D, Thomas J, Braaten T, Clardy S, Elgort M, Spivak E, Slev P, Peterson L, Frech T (2020). Assessing Cytokine Profiles and COVID Serology in Patients on Immunosuppression to Guide Care Recommendations [Abstract]. 72.
Walsh JA, Wan MT, Willinger C, Husni ME, Scher JU, Reddy SM, Ogdie A (2019). Measuring Outcomes in Psoriatic Arthritis: Comparing Routine Assessment of Patient Index Data and Psoriatic Arthritis Impact of Disease. J Rheumatol, 47(10), 1496-1505.
Quinn KA, Gribbons KB, Carette S, Cuthbertson D, Khalidi NA, Koening CL, Langford CA, McAlear CA, Monach PA, Moreland LW, Pagnoux C, Seo P, Sreih AG, Warrington KJ, Ytterberg SR, Novakovich E, Merkel PA, Grayson PC (2020). Patterns of clinical presentation in Takayasu's arteritis. Semin Arthritis Rheum, 50(4), 576-581.
Hughes M, Pauling JD, Jones J, Denton CP, Domsic RT, Frech TM, Herrick AL, Khanna D, Matucci-Cerinic M, McKenzie L, Saketkoo LA, Gooberman-Hill R, Moore A (2019). Patient experiences of digital ulcer development and evolution in systemic sclerosis. Rheumatology (Oxford), 59(8), 2156-2158.
Walsh JA, Cai Q, Lin I, Fitzgerald T, Pericone CD, Chakravarty SD (2020). Real-world 2-year treatment patterns among patients with psoriatic arthritis treated with injectable biologic therapies. Curr Med Res Opin, 36(7), 1245-1252.
Rodriguez-Pla A, Warner RL, Cuthbertson D, Carette S, Khalidi NA, Koening CL, Langford CA, McAlear CA, Moreland LW, Pagnoux C, Seo P, Specks U, Sreih AG, Ytterberg SR, Johnson KJ, Merkel PA, Monach PA, Vasculitis Clinical Research Consortium (2019). Evaluation of Potential Serum Biomarkers of Disease Activity in Diverse Forms of Vasculitis. J Rheumatol, 47(7), 1001-1010.
Aranow C, Cush J, Bolster MB, Striebich CC, Dallera M, Mackay M, Olech E, Frech T, Box J, Keating R, Wasko MC, St Clair W, Kivitz A, Huang W, Ricketts P, Welch B, Callahan S, Spychala M, Boyle K, York K, Keyes-Elstein L, Goldmuntz E, Diamond B, Davidson A (2019). A double-blind, placebo-controlled, phase II, randomized study of lovastatin therapy in the treatment of mildly active rheumatoid arthritis. Rheumatology (Oxford), 59(7), 1505-1513.
Bernstein EJ, Jaafar S, Assassi S, Domsic RT, Frech TM, Gordon JK, Broderick RJ, Hant FN, Hinchcliff ME, Shah AA, Shanmugam VK, Steen VD, Khanna D (2020). Performance Characteristics of Pulmonary Function Tests for the Detection of Interstitial Lung Disease in Adults with Early Diffuse Cutaneous Systemic Sclerosis. (Epub ahead of print) Arthritis Rheumatol.
Thomas J, Radic M, Tucker JR, Overbury R, Frech TM (2020). Raynaud Phenomenon in Systemic Sclerosis: Does Digital Thermal Monitoring Correlate to Specific Nailfold Videocapillaroscopy Abnormalities? (Epub ahead of print) J Rheumatol.
Overbury RS, Pei S, Breviu B, Clegg DO, Walsh JA (2020). Obstructive sleep apnea and fatigue in patients with inflammatory arthritis taking TNF-inhibitors. International Journal of Clinical Rheumatology, 15(3), 38.
Overbury RS, Pei S, Breviu B, Clegg DO, Walsh JA (2020). Obstructive sleep apnea and fatigue in patients with inflammatory arthritis taking TNF-inhibitors. International Journal of Clinical Rheumatology, 15(3), 38.
Goel R, Gribbons KB, Carette S, Cuthbertson D, Hoffman GS, Joseph G, Khalidi NA, Koening CL, Kumar S, Langford C, Maksimowicz-McKinnon K, McAlear CA, Monach PA, Moreland LW, Nair A, Pagnoux C, Quinn KA, Ravindran R, Seo P, Sreih AG, Warrington KJ, Ytterberg SR, Merkel PA, Danda D, Grayson PC (2019). Derivation of an angiographically based classification system in Takayasu's arteritis: an observational study from India and North America. Rheumatology (Oxford), 59(5), 1118-1127.
Hughes M, Pauling JD, Jones J, Denton CP, Domsic RT, Frech TM, Herrick AL, Khanna D, Matucci-Cerinic M, McKenzie L, Saketkoo LA, Gooberman-Hill R, Moore A (2019). Multicenter Qualitative Study Exploring the Patient Experience of Digital Ulcers in Systemic Sclerosis. Arthritis Care Res (Hoboken), 72(5), 723-733.
Spiera R, Hummers L, Chung L, Frech TM, Domsic R, Hsu V, Furst DE, Gordon J, Mayes M, Simms R, Lafyatis R, Martyanov V, Wood T, Whitfield ML, Constantine S, Lee E, Dgetluck N, White B (2020). Safety and Efficacy of Lenabasum in a Phase II, Randomized, Placebo-Controlled Trial in Adults With Systemic Sclerosis. (Epub ahead of print) Arthritis Rheumatol.
Carrier ME, Kwakkenbos L, Nielson WR, Fedoruk C, Nielsen K, Milette K, Pope J, Frech T, Gholizadeh S, Hummers L, Johnson SR, Piotrowski P, Jewett L, Gordon J, Chung L, Bilsker D, Turner KA, Cumin J, Welling J, Fortune C, Leite C, Gottesman K, Sauve M, Rodrguez-Reyna TS, Hudson M, Larche M, van Breda W, Suarez-Almazor ME, Bartlett SJ, Malcarne VL, Mayes MD, Boutron I, Mouthon L, Wigley F, Thombs BD, SPIN Investigators (2020). The Scleroderma Patient-Centered Intervention Network Self-Management Program: Protocol for a Randomized Feasibility Trial. JMIR Res Protoc, 9(4), e16799.
Haberman R, Perez-Chada L, Siegel E, Reginato A, Webster D, Chandran V, Walsh JA Rosen C, Reddy S, Ogdie A, Scher J, Merola J (2020). Psoriasis and Psoriatic Arthritis Clinics Multicenter Advancement Network Consortium (PPACMAN) 2018 Annual Meeting Summary. J Psoriasis Psoriatic Arthritis.
Harb S, Cumin J, Rice DB, Pelez S, Hudson M, Bartlett SJ, Roren A, Furst DE, Frech TM, Nguyen C, Nielson WR, Thombs BD, Shrier I, Scleroderma Patient-centered Intervention Network Physical Activity Enhancement Patient Advisory Team (2020). Identifying barriers and facilitators to physical activity for people with scleroderma: a nominal group technique study. Disabil Rehabil, 1-8.
Davis-Porada J, Kim MY, Guerra MM, Laskin CA, Petri M, Lockshin MD, Sammaritano LR, Branch DW, Sawitzke A, Merrill JT, Buyon JP, Salmon JE (2020). Low frequency of flares during pregnancy and post-partum in stable lupus patients. Arthritis Research & Therapy, 22(1), 52.
Skaug B, Khanna D, Swindell WR, Hinchcliff ME, Frech TM, Steen VD, Hant FN, Gordon JK, Shah AA, Zhu L, Zheng WJ, Browning JL, Barron AMS, Wu M, Visvanathan S, Baum P, Franks JM, Whitfield ML, Shanmugam VK, Domsic RT, Castelino FV, Bernstein EJ, Wareing N, Lyons MA, Ying J, Charles J, Mayes MD, Assassi S (2019). Global skin gene expression analysis of early diffuse cutaneous systemic sclerosis shows a prominent innate and adaptive inflammatory profile. Ann Rheum Dis, 79(3), 379-386.
Smith V, Herrick AL, Ingegnoli F, Damjanov N, De Angelis R, Denton CP, Distler O, Espejo K, Foeldvari I, Frech T, Garro B, Gutierrez M, Gyger G, Hachulla E, Hesselstrand R, Iagnocco A, Kayser C, Melsens K, Mller-Ladner U, Paolino S, Pizzorni C, Radic M, Riccieri V, Snow M, Stevens W, Sulli A, van Laar JM, Vonk MC, Vanhaecke A, Cutolo M, EULAR Study Group on Microcirculation in Rheumatic Diseases and the Scleroderma Clinical Trials Consortium Group on Capillaroscopy (2020). Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosis. Autoimmun Rev, 19(3), 102458.
Battistone MJ, Barker AM, Durning SJ (2019). Interprofessional Musculoskeletal Education: A Review of National Initiatives from the Department of Veterans Affairs. Rheum Dis Clin North Am, 46(1), 135-153.
Dougados M, Wei JC, Landew R, Sieper J, Baraliakos X, Van den Bosch F, Maksymowych WP, Ermann J, Walsh JA, Tomita T, Deodhar A, van der Heijde D, Li X, Zhao F, Bertram CC, Gallo G, Carlier H, Gensler LS, COAST-V and COAST-W Study Groups (2019). Efficacy and safety of ixekizumab through 52 weeks in two phase 3, randomised, controlled clinical trials in patients with active radiographic axial spondyloarthritis (COAST-V and COAST-W). Ann Rheum Dis, 79(2), 176-185.
Moran SM, Monach PA, Zgaga L, Cuthbertson D, Carette S, Khalidi NA, Koening CL, Langford CA, McAlear CA, Moreland L, Pagnoux C, Seo P, Specks U, Sreih A, Wyse J, Ytterberg SR, Merkel PA, Little MA, Vasculitis Clinical Research Consortium (2018). Urinary soluble CD163 and monocyte chemoattractant protein-1 in the identification of subtle renal flare in anti-neutrophil cytoplasmic antibody-associated vasculitis. Nephrol Dial Transplant, 35(2), 283-291.
Walsh JA, Pei S, Penmetsa G, Hansen JL, Cannon GW, Clegg DO, Sauer BC (2019). Identification of Axial Spondyloarthritis Patients in a Large Dataset: The Development and Validation of Novel Methods. J Rheumatol, 47(1), 42-49.
Barker AM, LaRochelle JS, Artino AR Jr, Wiltz SA, Kim LM, Battistone MJ (2020). SimLEARN Musculoskeletal Training for VHA Primary Care Providers and Health Professions Educators. Fed Pract, 37(1), 42-47.
Shanmugam VK, Frech TM, Steen VD, Hummers LK, Shah AA, Bernstein EJ, Khanna D, Gordon JK, Castelino FV, Chung L, Hant FN, Startup E, VanBuren JM, Evnin LB, Assassi S (2019). Collaborative National Quality and Efficacy Registry (CONQUER) for Scleroderma: outcomes from a multicenter US-based systemic sclerosis registry. Clin Rheumatol, 39(1), 93-102.
Khanna D, Spino C, Johnson S, Chung L, Whitfield ML, Denton CP, Berrocal V, Franks J, Mehta B, Molitor J, Steen VD, Lafyatis R, Simms RW, Gill A, Kafaja S, Frech TM, Hsu V, Domsic RT, Pope JE, Gordon JK, Mayes MD, Schiopu E, Young A, Sandorfi N, Park J, Hant FN, Bernstein EJ, Chatterjee S, Castelino FV, Ajam A, Wang Y, Wood T, Allanore Y, Matucci-Cerinic M, Distler O, Singer O, Bush E, Fox DA, Furst DE (2019). Abatacept in Early Diffuse Cutaneous Systemic Sclerosis: Results of a Phase II Investigator-Initiated, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial. Arthritis Rheumatol, 72(1), 125-136.
Quinn KA, Gelbard A, Sibley C, Sirajuddin A, Ferrada MA, Chen M, Cuthbertson D, Carette S, Khalidi NA, Koening CL, Langford CA, McAlear CA, Monach PA, Moreland LW, Pagnoux C, Seo P, Specks U, Sreih AG, Ytterberg SR, Merkel PA, Grayson PC (2019). Subglottic stenosis and endobronchial disease in granulomatosis with polyangiitis. Rheumatology (Oxford), 58(12), 2203-2211.
Deodhar A, Gensler LS, Magrey M, Walsh JA, Winseck A, Grant D, Mease PJ (2019). Assessing Physical Activity and Sleep in Axial Spondyloarthritis: Measuring the Gap. Rheumatol Ther, 6(4), 487-501.
Overbury RS, Bohnsack J, Inman CJ, Stern S, James K, Clegg DO, Frech TM, Hersh AO (2019). Implementation of an Evidence-based Transition Clinic in a Pediatric Rheumatology Academic Institution [Abstract].
Overbury RS, Pei S, Penmetsa GK, Sauer BC, Patil V, Walker JH, Clewell J, Douglas KM, Clegg DO, Cannon GW, Halwani A, Walsh JA (2019). Treatment Patterns with Disease Modifying Anti-rheumatic Drugs in United States Veterans with Newly Diagnosed Rheumatoid Arthritis, Psoriatic Arthritis, or Ankylosing Spondylitis [Abstract].
Overbury RS, Hersh AO, Inman CJ, Stern S, James K, Bohnsack J (2019). Long Term Outcomes of Childhood Onset Rheumatoid Arthritis [Abstract].
Overbury RS, Pupaibool J, Hansen C, Clegg DO, Lebiedz-Odrobina D (2019). Hydroxychloroquine (HCQ) Prescribing Habits and Provider Opinion on Dosing Guidelines in the Rheumatology and Dermatology Practices of an Academic Institution [Abstract].
Radic M, Overbury RS, Frech TM (2019). Does Digital Thermal Monitoring Correlate to Specific Nailfold Videocapillaroscopy Abnormalities? [Abstract].
Walsh JA, Pei S, Penmetsa GK, Sauer BC, Patil V, Walker JH, Clewell J, Douglas KM, Clegg DO, Cannon GW, Halwani A (2019). Treatment Patterns with Disease-Modifying Antirheumatic Drugs in U.S. Veterans with Newly Diagnosed Rheumatoid Arthritis, Psoriatic Arthritis, or Ankylosing Spondylitis. J Manag Care Spec Pharm, 25(11), 1218-1228.
Tebo AE, Schmidt RL, Frech TM (2019). Dr. Tebo, et al, reply. [Letter to the editor]. J Rheumatol, 46(11), 1547.
Pauling JD, Frech TM (2019). Pauling and Frech reply. [Letter to the editor]. J Rheumatol, 46(11), 1544-1545.
Radic M, Thomas J, Frech T (2019). Comparison of Automated Capture and Analysis System of Sublingual Microvessels and Nailfold Videocapillarscopy for Microvascular Assessment in Systemic Sclerosis [Abstract]. 71(suppl 10), 1645.
Pauling JD, Reilly E, Smith T, Frech TM (2019). Factors Influencing Raynaud Condition Score Diary Outcomes in Systemic Sclerosis. J Rheumatol, 46(10), 1326-1334.
Walsh J, Hunter T, Schroeder K, Sandoval D, Bolce R (2019). Trends in diagnostic prevalence and treatment patterns of male and female ankylosing spondylitis patients in the United States, 2006-2016. BMC Rheumatol, 3, 39.
Nagaraja V, Spino C, Bush E, Tsou PS, Domsic RT, Lafyatis R, Frech T, Gordon JK, Steen VD, Khanna D (2019). A multicenter randomized, double-blind, placebo-controlled pilot study to assess the efficacy and safety of riociguat in systemic sclerosis-associated digital ulcers. Arthritis Research & Therapy, 21(1), 202.
Mease P, Walsh JA, Baraliakos X, Inman R, de Vlam K, Wei JC, Hunter T, Gallo G, Sandoval D, Zhao F, Dong Y, Bolce R, Marzo-Ortega H (2019). Translating Improvements with Ixekizumab in Clinical Trial Outcomes into Clinical Practice: ASAS40, Pain, Fatigue, and Sleep in Ankylosing Spondylitis. Rheumatol Ther, 6(3), 435-450.
Coit P, Kaushik P, Caplan L, Kerr G, Walsh JA, Dubreuil M, Reimold A, Sawalha A (2019). Genome-wide DNA methylation analysis in ankylosing spondylitis identifies HLA-B*27 dependent and independent DNA methylation changes in whole blood. J Autoimmun, 102, 126-132.
Tomasson G, Farrar JT, Cuthbertson D, McAlear CA, Ashdown S, Cronholm PF, Dawson J, Gebhart D, Lanier G, Luqmani RA, Milman N, Peck J, Robson JC, Shea JA, Carette S, Khalidi N, Koening CL, Langford CA, Monach PA, Moreland L, Pagnoux C, Specks U, Sreih AG, Ytterberg SR, Merkel PA, Vasculitis Clinical Research Consortium (2019). Feasibility and Construct Validation of the Patient Reported Outcomes Measurement Information System in Systemic Vasculitis. J Rheumatol, 46(8), 928-934.
Frech TM, Murtaugh MA (2019). Non-invasive digital thermal monitoring and flow-mediated dilation in systemic sclerosis. Clin Exp Rheumatol, 37 Suppl 119(4), 97-101.
Snow MH, Saketkoo LA, Frech TM, Stever JR, Lebedoff N, Herrick AL, Cutolo M, Smith V (2019). Results from an American pilot survey among Scleroderma Clinical Trials Consortium members on capillaroscopy use and how to best implement nailfold capillaroscopy training. [Letter to the editor]. Clin Exp Rheumatol, 37 Suppl 119(4), 151.
Stever JR, Cannon GW, Teng CC, Accortt NA, Collier DH, Sauer BC (2018). Utility of administrative and clinical data to predict major change in medical treatment in US Veterans enrolled in the Veterans Affairs Rheumatoid Arthritis (VARA) registry. Clin Exp Rheumatol, 37(4), 552-560.
Walsh JA, Rozycki M, Yi E, Park Y (2019). Application of machine learning in the diagnosis of axial spondyloarthritis. Curr Opin Rheumatol, 31(4), 362-367.
Snow MH, Saketkoo LA, Frech TM, Stever JR, Lebedoff N, Herrick AL, Cutolo M, Smith V (2019). Results from an American pilot survey among Scleroderma Clinical Trials Consortium members on capillaroscopy use and how to best implement nailfold capillaroscopy training. [Letter to the editor]. Clin Exp Rheumatol, 37 Suppl 119(4), 151.
Nelson RE, Ma J, Miller K, Lawrence P, LaFleur J, Grotzke M, Barker A, Cannon GW, Battistone MJ (2019). The impact of a musculoskeletal training program on residents' recognition and treatment of osteoporosis. BMC Med Educ, 19(1), 223.
Nelson RE, Ma J, Miller K, Lawrence P, LaFleur J, Grotzke M, Barker A, Cannon GW, Battistone MJ (2019). The impact of a musculoskeletal training program on residents' recognition and treatment of osteoporosis. BMC Med Educ, 19(1), 223.
Nelson RE, Ma J, Miller K, Lawrence P, LaFleur J, Grotzke M, Barker A, Cannon GW, Battistone MJ (2019). The impact of a musculoskeletal training program on residents' recognition and treatment of osteoporosis. BMC Med Educ, 19(1), 223.
Butler EA, Baron M, Fogo AB, Frech T, Ghossein C, Hachulla E, Hoa S, Johnson SR, Khanna D, Mouthon L, Nikpour M, Proudman S, Steen V, Stern E, Varga J, Denton C, Hudson M, Scleroderma Clinical Trials Consortium Scleroderma Renal Crisis Working Group (2019). Generation of a Core Set of Items to Develop Classification Criteria for Scleroderma Renal Crisis Using Consensus Methodology. Arthritis Rheumatol, United States, 71(6), 964-971.
Braaten TJ, Zhang C, Presson AP, Breviu B, Clegg DO, Walsh JA (2019). Gender Differences in Psoriatic Arthritis with Fatigue, Pain, Function and Work Disability. J Psoriasis Psoriatic Arthritis, 4(4), 192-197.
Farahi JM, Lynn BS, Anand P, Smith DH, Walsh JA, Hashim M, Duong R, Dellavalle RP, Reimold A, Kerr, GS, Richards JS, Chang E, Kaushik P, Dubreuil M, Caplan L (2019). A Prospective Cross-Sectional Analysis of Construct Validity for the PALMPASS, A Brief Patient-Reported Outcome Measure for Psoriasis. J Psoriasis Psoriatic Arthritis, 4(4), 186-191.
Hong S, Banchereau R, Maslow BL, Guerra MM, Cardenas J, Baisch J, Branch DW, Porter TF, Sawitzke A, Laskin CA, Buyon JP, Merrill J, Sammaritano LR, Petri M, Gatewood E, Cepika AM, Ohouo M, Obermoser G, Anguiano E, Kim TW, Nulsen J, Nehar-Belaid D, Blankenship D, Turner J, Banchereau J, Salmon JE, Pascual V (2019). Longitudinal profiling of human blood transcriptome in healthy and lupus pregnancy. J Exp Med, 216(5), 1154-1169.
Wong K-H, Fang W, Skalabrin E, Sawitzke A, Zamrini E, Salzman K, Stoddard G, Davidson C, Anderson J, Majersik J (2019). Focal Parietal Lobe Atrophy in Antiphospholipid Syndrome: Retrospective Analysis [Abstract]. 92(15_supplement), 5.3-055.
Frech TM, McNeill C, Lebiedz-Odrobina D, Lewis G (2018). Amniotic membrane dressings: an effective therapy for SSc-related wounds. [Letter to the editor]. Rheumatology (Oxford), 58(4), 734-736.
Tebo AE, Schmidt RL, Frech TM (2019). Presence of Antitopoisomerase I Antibody Alone May Not Be Sufficient for the Diagnosis of Systemic Sclerosis. [Letter to the editor]. J Rheumatol, 46(4), 440-442.
Walsh JA, Song X, Kim G, Park Y (3/24/2019). Counting the Costs of Ankylosing Spondylitis. Research Outreach, 2517(106), 82-85.
Walsh JA, Pei S, Penmetsa G, Hansen JL, Cannon GW, Clegg DO, Sauer BC (2019). Identification of Axial Spondyloarthritis Patients in a Large Dataset: The Development and Validation of Novel Methods. (Epub ahead of print) J Rheumatol.
Zhu J, Frech T (2019). Gut disease in systemic sclerosis - new approaches to common problems. Curr Treatm Opt Rheumatol, 5(1), 11-19.
Pagnoux C, Nair P, Xi Y, Khalidi NA, Carette S, Cuthbertson D, Grayson PC, Koening CL, Langford CA, McAlear CA, Moreland LW, Monach PA, Seo P, Specks U, Sreih AG, Ytterberg SR, Tyrrell PN, Merkel PA, Vasculitis Clinical Research Consortium (2019). Serum cytokine and chemokine levels in patients with eosinophilic granulomatosis with polyangiitis, hypereosinophilic syndrome, or eosinophilic asthma. Clin Exp Rheumatol, 37 Suppl 117(2), 40-44.
Baron M, Kahaleh B, Bernstein EJ, Chung L, Clements PJ, Denton C, Domsic RT, Ferdowsi N, Foeldvari I, Frech T, Gordon JK, Hudson M, Johnson SR, Khanna D, McMahan Z, Merkel PA, Narain S, Nikpour M, Pauling JD, Ross L, Valenzuela Vergara AM, Vacca A (2018). An Interim Report of the Scleroderma Clinical Trials Consortium Working Groups. J Scleroderma Relat Disord, 4(1), 17-27.
Kermani TA, Diab S, Sreih AG, Cuthbertson D, Borchin R, Carette S, Forbess L, Koening CL, McAlear CA, Monach PA, Moreland L, Pagnoux C, Seo P, Spiera RF, Warrington KJ, Ytterberg SR, Langford CA, Merkel PA, Khalidi NA, Vasculitis Clinical Research Consortium (2018). Arterial lesions in giant cell arteritis: A longitudinal study. Semin Arthritis Rheum, 48(4), 707-713.
Singh JA, Guyatt G, Ogdie A, Gladman DD, Deal C, Deodhar A, Dubreuil M, Dunham J, Husni ME, Kenny S, Kwan-Morley J, Lin J, Marchetta P, Mease PJ, Merola JF, Miner J, Ritchlin CT, Siaton B, Smith BJ, Van Voorhees AS, Jonsson AH, Shah AA, Sullivan N, Turgunbaev M, Coates LC, Gottlieb A, Magrey M, Nowell WB, Orbai AM, Reddy SM, Scher JU, Siegel E, Siegel M, Walsh JA, Turner AS, Reston J (2018). Special Article: 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis. Arthritis Care Res (Hoboken), 71(1), 2-29.
Singh JA, Guyatt G, Ogdie A, Gladman DD, Deal C, Deodhar A, Dubreuil M, Dunham J, Husni ME, Kenny S, Kwan-Morley J, Lin J, Marchetta P, Mease PJ, Merola JF, Miner J, Ritchlin CT, Siaton B, Smith BJ, Van Voorhees AS, Jonsson AH, Shah AA, Sullivan N, Turgunbaev M, Coates LC, Gottlieb A, Magrey M, Nowell WB, Orbai AM, Reddy SM, Scher JU, Siegel E, Siegel M, Walsh JA, Turner AS, Reston J (2018). Special Article: 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis. Arthritis Rheumatol, 71(1), 5-32.
McMahan ZH, Frech T, Berrocal V, Lim D, Bruni C, Matucci-Cerinic M, Smith V, Melsens K, Proudman S, Zhang J, Mendoza F, Woods M, Khanna D (2018). Longitudinal Assessment of Patient-reported Outcome Measures in Systemic Sclerosis Patients with Gastroesophageal Reflux Disease - Scleroderma Clinical Trials Consortium. J Rheumatol, 46(1), 78-84.
Frech T, McNeill C, Lebiedz-Odrobina D, Lewis G (2019). Amniotic membrane dressings: an effective therapy for SSc-related wounds. Rheumatology, 58(4), 734–736.
Walsh JA, Song X, Kim G, Park Y (2018). Healthcare Utilization and Direct Costs in Patients with Ankylosing Spondylitis Using a Large US Administrative Claims Database. Rheumatol Ther, 5(2), 463-474.
Walsh JA, Gottlieb AB, Hoepken B, Nurminen T, Mease PJ (2018). Efficacy of certolizumab pegol with and without concomitant use of disease-modifying anti-rheumatic drugs over 4 years in psoriatic arthritis patients: results from the RAPID-PsA randomized controlled trial. Clin Rheumatol, 37(12), 3285-3296.
Sreih AG, Ezzedine R, Leng L, Fan J, Yao J, Reid D, Piecychna M, Carette S, Cuthbertson D, Dellaripa P, Hoffman GS, Khalidi NA, Koening CL, Langford CA, Mahr A, McAlear CA, Maksimowicz-Mckinnon K, Monach PA, Seo P, Specks U, St Clair EW, Stone JH, Ytterberg SR, Edberg J, Merkel PA, Bucala R (2018). Role of Macrophage Migration Inhibitory Factor in Granulomatosis With Polyangiitis. Arthritis Rheumatol, 70(12), 2077-2086.
Walsh JA, Song X, Kim G, Park Y (2018). Evaluation of the comorbidity burden in patients with ankylosing spondylitis using a large US administrative claims data set. J Cardiol Cardiovasc Sci, 2(6), 17-23.
Hanrahan CJ, Lindley, MD, Mueller, M, Kim, D, Sommers, D, Morrell, G, Redd, A, Carlston, K, and Lee, VS (2018). Diagnostic Accuracy of Non-Contrast Magnetic Resonance Angiography Protocols at 3 Tesla for the Detection and Characterization of Lower Extremity Peripheral Arterial Disease. J Vasc Interv Radiol, 29(11), 1585-1594.e2.
Miller KL, Patel S, Cannon GW, Anderson ZL (2018). Implementation of a Primary Prevention, Population-Based Virtual Osteoporosis Clinic Dramatically Increases the Number of Rural Veterans Receiving Osteoporosis Screening and Treatment [Abstract]. Arthritis Rheumatol, 70(suppl 10).
Patel S, Anderson ZL, Cannon GW, Sauer BC, Miller KL (2018). A Customized Health Information Technology Effectively Identifies and Directs Bone Health Services in Rural Veterans with Osteoporosis Risk Factor [Abstract]. Arthritis Rheumatol, 70(suppl 10).
Overbury RS, Pei S, Penmetsa G, Cannon GW, Clegg DO, Sauer B, Walsh J (2018). Identification of Axial Spondyloarthritis Patients in a Large Dataset: The Development and Validation of Novel Methods [Abstract]. Arthritis Rheumatol, 70(suppl 10).
Rhee RL, Holweg CTJ, Wong K, Cuthbertson D, Carette S, Khalidi NA, Koening CL, Langford CA, McAlear CA, Monach PA, Moreland LW, Pagnoux C, Seo P, Specks U, Sreih AG, Ytterberg SR, Merkel PA, Vasculitis Clinical Research Consortium (2018). Serum periostin as a biomarker in eosinophilic granulomatosis with polyangiitis. PLoS ONE, 13(10), e0205768.
Walsh JA, Jones H, Mallbris L, Duffin KC, Krueger GG, Clegg DO, Szumski A (2018). The Physician Global Assessment and Body Surface Area composite tool is a simple alternative to the Psoriasis Area and Severity Index for assessment of psoriasis: post hoc analysis from PRISTINE and PRESTA. Psoriasis (Auckl), 8, 65-74.
Pauling JD, Frech TM, Hughes M, Gordon JK, Domsic RT, Anderson ME, Ingegnoli F, McHugh NJ, Johnson SR, Hudson M, Boin F, Ong VH, Matucci-Cerinic M, Altorok N, Scolnik M, Nikpour M, Shah A, Pope JE, Khanna D, Herrick AL (2018). Patient-reported outcome instruments for assessing Raynaud's phenomenon in systemic sclerosis: A SCTC Vascular Working Group Report. J Scleroderma Relat Disord, 3(3), 249-252.
Clifton HL, Machin DR, Groot HJ, Frech TM, Donato AJ, Richardson RS, Wray DW (2018). Attenuated nitric oxide bioavailability in systemic sclerosis: Evidence from the novel assessment of passive leg movement. Exp Physiol, 103(10), 1412-1424.
Bruni C, Frech T, Manetti M, Rossi FW, Furst DE, De Paulis A, Rivellese F, Guiducci S, Matucci-Cerinic M, Bellando-Randone S (2018). Vascular Leaking, a Pivotal and Early Pathogenetic Event in Systemic Sclerosis: Should the Door Be Closed? Front Immunol, 9, 2045.
Walsh JA, Pei S, Penmetsa GK, Leng J, Cannon GW, Clegg DO, Sauer BC (2018). Cohort identification of axial spondyloarthritis in a large healthcare dataset: current and future methods. BMC Musculoskelet Disord, 19(1), 317.
Pauling JD, Domsic RT, Saketkoo LA, Almeida C, Withey J, Jay H, Frech TM, Ingegnoli F, Dures E, Robson J, McHugh NJ, Herrick AL, Matucci-Cerinic M, Khanna D, Hewlett S (2018). Multinational Qualitative Research Study Exploring the Patient Experience of Raynaud's Phenomenon in Systemic Sclerosis. Arthritis Care Res (Hoboken), 70(9), 1373-1384.
Dougherty DH, Kwakkenbos L, Carrier ME, Salazar G, Assassi S, Baron M, Bartlett SJ, Furst DE, Gottesman K, van den Hoogen F, Malcarne VL, Mouthon L, Nielson WR, Poiraudeau S, Sauv M, Boire G, Bruns A, Chung L, Denton C, Dunne JV, Fortin P, Frech T, Gill A, Gordon J, Herrick AL, Hinchcliff M, Hudson M, Johnson SR, Jones N, Kafaja S, Larch M, Manning J, Pope J, Spiera R, Steen V, Sutton E, Thorne C, Wilcox P, Thombs BD, Mayes MD, SPIN Investigators (2017). The Scleroderma Patient-Centered Intervention Network Cohort: baseline clinical features and comparison with other large scleroderma cohorts. Rheumatology (Oxford), 57(9), 1623-1631.
Nelson Roy, PhD, Kristine M Tanner, PhD, Ray M Merrill, PhD, MPH, Charisse Wright, MS, Jenny L Pierce, MS, and Miller KL (2018). Epidemiology of Swallowing Disorders in Rheumatoid Arthritis: Prevalence, Risk Factors, and Quality of Life Burden. Ann Otol Rhinol Laryngol, 127(9), 577-587.
Pauling JD, Reilly E, Smith T, Frech TM (2018). Evolving Symptom Characteristics of Raynaud's Phenomenon in Systemic Sclerosis and Their Association With Physician and Patient-Reported Assessments of Disease Severity. (Epub ahead of print) Arthritis Care Res (Hoboken).
Frech TM, Hess R, Biber J, Young J, Hardman A, Weeks H, Peterson KA, Scholand MB (2018). Can Routine Use of Patient-Reported Outcomes Help Guide Systemic Sclerosis Chronic Disease Care? J Clin Rheumatol, 24(5), 272-274.
Frech TM, Machin DR, Murtaugh MA, Stoddard GJ, Bloom SI, Phibbs JV, Donato AJ (2018). Implications of endothelial shear stress on systemic sclerosis vasculopathy and treatment. Clin Exp Rheumatol, 36 Suppl 113(4), 175-182.
Walsh JA, Arledge T, Nurminen T, Peterson L, Stark J (2018). PGA×BSA: A Measure of Psoriasis Severity Tested in Patients with Active Psoriatic Arthritis and Treated with Certolizumab Pegol. J Rheumatol, 45(7), 922-928.
Walsh JA, Adejoro O, Chastek B, Palmer JB, Hur P (2018). Treatment Patterns Among Patients with Psoriatic Arthritis Treated with a Biologic in the United States: Descriptive Analyses from an Administrative Claims Database. J Manag Care Spec Pharm, 24(7), 623-631.
Walsh JA, Song X, Kim G, Park Y (2018). Evaluation of the comorbidity burden in patients with ankylosing spondylitis using a large US administrative claims data set. Clin Rheumatol, 37(7), 1869-1878.
Morrisroe K, Hudson M, Baron M, de Vries-Bouwstra J, Carreira PE, Wuttge DM, Wang M, Frech TM, Stevens W, Proudman SM, Nikpour M, International Systemic Sclerosis Inception Cohort INSYNC collaboration (2018). Determinants of health-related quality of life in a multinational systemic sclerosis inception cohort. Clin Exp Rheumatol, 36 Suppl 113(4), 53-60.
Jurynec MJ, Sawitzke AD, Beals TC, Redd MJ, Stevens J, Otterud B, Leppert MF, Grunwald DJ (2018). A hyperactivating proinflammatory RIPK2 allele associated with early-onset osteoarthritis. Hum Mol Genet, 27(13), 2383-2391.
Walsh JA, Song X, Kim G, Park Y (2018). Evaluation of the comorbidity burden in patients with ankylosing spondylitis treated with tumour necrosis factor inhibitors using a large administrative claims data set. J Pharm Health Serv Res, 9(2), 115-121.
Nash P, Ohson K, Walsh J, Delev N, Nguyen D, Teng L, Gmez-Reino JJ, Aelion JA, ACTIVE investigators (2018). Early and sustained efficacy with apremilast monotherapy in biological-naïve patients with psoriatic arthritis: a phase IIIB, randomised controlled trial (ACTIVE). Ann Rheum Dis, 77(5), 690-698.
Walsh JA, Adejoro O, Chastek B, Park Y (2017). Treatment patterns of biologics in US patients with ankylosing spondylitis: descriptive analyses from a claims database. Journal of Comparative Effectiveness Research, 7(4), 369-380.
Walsh JA, Adejoro O, Chastek B, Palmer JB, Hur P (2018). Treatment Patterns Among Patients with Psoriatic Arthritis Treated with a Biologic in the United States: Descriptive Analyses from an Administrative Claims Database. J Manag Care Spec Pharm, 1-11.
Walsh JA, Pei S, Burningham Z, Penmetsa G, Cannon GW, Clegg DO, Sauer BC (2017). Use of Disease-modifying Antirheumatic Drugs for Inflammatory Arthritis in US Veterans: Effect of Specialty Care and Geographic Distance. J Rheumatol, 45(3), 430-436.
Frech TM, Mar D (2017). Gastrointestinal and Hepatic Disease in Systemic Sclerosis. Rheum Dis Clin North Am, 44(1), 15-28.
Khanna D, Denton CP, Lin CJF, van Laar JM, Frech TM, Anderson ME, Baron M, Chung L, Fierlbeck G, Lakshminarayanan S, Allanore Y, Pope JE, Riemekasten G, Steen V, Mller-Ladner U, Spotswood H, Burke L, Siegel J, Jahreis A, Furst DE (2017). Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate). Ann Rheum Dis, 77(2), 212-220.
Lebedoff N, Frech TM, Shanmugam VK, Fischer A, Erhardt D, Kolfenbach J, Kohler K, Bernhisel K, Lewis GM (2017). Review of local wound management for scleroderma-associated digital ulcers. J Scleroderma Relat Disord, 3(1), 66-70.
Kermani TA, Sreih AG, Cuthbertson D, Carette S, Hoffman GS, Khalidi NA, Koening CL, Langford CA, McAlear CA, Monach PA, Moreland L, Pagnoux C, Seo P, Warrington KJ, Ytterberg SR, Merkel PA, Vasculitis Clinical Research Consortium (2017). Evaluation of damage in giant cell arteritis. Rheumatology (Oxford), 57(2), 322-328.
Overbury RS, Murtaugh MA, Frech TM, Steenon VD (2018). A normal diffusing capacity of the lungs for carbon monoxide is rare in incidental pulmonary arterial hypertension in systemic sclerosis: Data from the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma cohort. J Scleroderma Relat Disord, 3(3), 237-241.
Arnold MB, Khanna D, Denton CP, van Laar JM, Frech TM, Anderson ME, Baron M, Chung L, Fierlbeck G, Lakshminarayanan S, Allanore Y, Riemekasten G, Steen V, Mller-Ladner U, Spotswood H, Burke L, Siegel J, Jahreis A, Furst DE, Pope JE (2017). Patient acceptable symptom state in scleroderma: results from the tocilizumab compared with placebo trial in active diffuse cutaneous systemic sclerosis. Rheumatology (Oxford), 57(1), 152-157.
Johnson SR, Soowamber ML, Fransen J, Khanna D, Van Den Hoogen F, Baron M, Matucci-Cerinic M, Denton CP, Medsger TA Jr, Carreira PE, Riemekasten G, Distler J, Gabrielli A, Steen V, Chung L, Silver R, Varga J, Mller-Ladner U, Vonk MC, Walker UA, Wollheim FA, Herrick A, Furst DE, Czirjak L, Kowal-Bielecka O, Del Galdo F, Cutolo M, Hunzelmann N, Murray CD, Foeldvari I, Mouthon L, Damjanov N, Kahaleh B, Frech T, Assassi S, Saketkoo LA, Pope JE (2017). There is a need for new systemic sclerosis subset criteria. A content analytic approach. Scand J Rheumatol, 47(1), 62-70.
Kramer GD, Lebiedz-Odrobina D, Mamalis N (2017). Amyloidosis Mimicking Temporal Arteritis in Multiple Myeloma. Ophthalmology, 124(12), 1798.
Elorreaga N, Allred D, Ortiz G, McNeill C, Scholand MB, Frech TM (2017). Implementation of an advance directive focus in a Chronic Multi-Organ Rare Disease Clinic. Ann Palliat Med, 6(Suppl 2), S206-S208.
Miller KL, King J, Lawrence P, Nelson R, Lafleur J, Cannon G, Nelson S (2017). Remote Management of Osteoporosis Screening and Treatment in US Veterans Using a Bone Health Team: A Cost-Effectiveness Analysis [Abstract]. Arthritis Rheumatol, 69(suppl 10).
Williams ST, Lawrence PT, Miller KL, Crook JL, LaFleur J, Cannon GW, Nelson RE (2017). A comparison of electronic and manual fracture risk assessment tools in screening elderly male US veterans at risk for osteoporosis. Osteoporos Int, 28(11), 3107-3111.
Machin DR, Gates PE, Vink H, Frech TM, Donato AJ (2017). Automated Measurement of Microvascular Function Reveals Dysfunction in Systemic Sclerosis: A Cross-sectional Study. J Rheumatol, 44(11), 1603-1611.
Williams ST, Lawrence PT, Miller KL, Crook JL, LaFleur J, Cannon GW, Nelson RE (2017). A comparison of electronic and manual fracture risk assessment tools in screening elderly male US veterans at risk for osteoporosis. Osteoporos Int, 28(11), 3107-3111.
Walsh JA, Tan H, Valdez H, Callis Duffin K (2017). Comparative Assessment of PASI and Variations of PGA×BSA as Measures of Psoriasis Severity. J Psoriasis Psoriatic Arthritis, 2(4), 113-118.
Frech TM, Fakoya L, Gawron AJ, Wong J, Scholand MB, Sawitzke A, Peterson K (2017). Oesophageal disease in systemic sclerosis: does heritability play a role? Clin Exp Rheumatol, 35 Suppl 106(4), 86-88.
Machin DR, Clifton HL, Richardson RS, Wray DW, Donato AJ, Frech TM (2017). Acute oral tetrahydrobiopterin administration ameliorates endothelial dysfunction in systemic sclerosis. Clin Exp Rheumatol, 35 Suppl 106(4), 167-172.
Walsh JA, Shao Y, Leng J, He T, Teng CC, Redd D, Treitler Zeng Q, Burningham Z, Clegg DO, Sauer BC (2017). Identifying Axial Spondyloarthritis in Electronic Medical Records of US Veterans. Arthritis Care Res (Hoboken), 69(9), 1414-1420.
van der Heijde D, Dougados M, Landew R, Sieper J, Maksymowych WP, Rudwaleit M, Van den Bosch F, Braun J, Mease PJ, Kivitz AJ, Walsh J, Davies O, Bauer L, Hoepken B, Peterson L, Deodhar A (2017). Sustained efficacy, safety and patient-reported outcomes of certolizumab pegol in axial spondyloarthritis: 4-year outcomes from RAPID-axSpA. Rheumatology (Oxford), 56(9), 1498-1509.
Li W, Frech TM (2017). The critical need for accurately defining digital ulcers in scleroderma. J Scleroderma Relat Disord, 2(2), 69-71.
Allred D, Frech TM, McComber C, Peterson K, Ortiz G, McNeill C, Broadbent L, Elorreaga N, Miller T, Scholand MB (2019). Chronic Multiorgan Rare Disease: The Role of the Nurse Practitioner as a Leader of the Healthcare Team. J Med Pract Manage, 32(6), 413-416.
Krischer J, Cronholm PF, Burroughs C, McAlear CA, Borchin R, Easley E, Davis R, Kullman J, Carette S, Khalidi N, Koening C, Langford C, Monach P, Moreland L, Pagnoux C, Specks U, Sreih AG, Ytterberg S, Merkel PA, Vasculitis Clinical Research Consortium (2017). Experience With Direct-to-Patient Recruitment for Enrollment Into a Clinical Trial in a Rare Disease: A Web-Based Study. J Med Internet Res, 19(2), 1-11.
Lawrence PT, Grotzke MP, Rosenblum Y, Nelson RE, LaFleur J, Miller KL, Ma J, Cannon GW (Published). The Bone Health Team: A Team-Based Approach to Improving Osteoporosis Care for Primary Care Patients. J Prim Care Community Health, I(6).
Battistone MJ, Barker AM, Beck JP, Tashjian RZ, Cannon GW (2017). Validity evidence for two objective structured clinical examination stations to evaluate core skills of the shoulder and knee assessment. BMC Med Educ, 17(1), 13.
Battistone MJ, Nelson RE, Ma J, Miller KM, Lawrence P, Lafleur J, Grotzke M, Barker AM, Cannon GW (2016). Impact of a Musculoskeletal Training Program on Residents’ Evaluation, Diagnosis, and Treatment of Osteoporosis [Abstract]. Arthritis Rheumatol, 68(suppl 10).
Miller KL, Frech TM, Greene, T, Ma K, McFadden M, Tom-Orme L, Moyer-Mileur L, Slattery ML, Murtaugh MA (5/2016). Bone Mineral Density in Navajo Men and Women and Comparison to Non-Hispanic Whites from NHANES (2005-2008). J Health Care Poor Underserved, 27((2)), 644-62.
Hochberg MC, Martel-Pelletier J, Monfort J, Mller I, Castillo JR, Arden N, Berenbaum F, Blanco FJ, Conaghan PG, Domnech G, Henrotin Y, Pap T, Richette P, Sawitzke A, du Souich P, Pelletier JP, MOVES Investigation Group (2016). Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib. Ann Rheum Dis, 75(1), 37-44.
Sauer BC, Teng CC, He T, Leng J, Lu CC, Walsh JA, Shah N, Harrison DJ, Tang DH, Cannon GW (2016). Treatment patterns and annual biologic costs in US veterans with rheumatic conditions or psoriasis. J Med Econ, 19(1), 34-43.
Overbury R, Murtaugh MA, Fischer A, Frech TM (2015). Primary care assessment of capillaroscopy abnormalities in patients with Raynaud's phenomenon. Clin Rheumatol, 34(12), 2135-40.
Pierce JL, Tanner K, Merrill RM, Miller KL, Kendall KA, Roy N (February 2016). Swallowing Disorders in Sjogren’s Syndrome: Prevalence, Risk Factors, and Effects on Quality of Life. Dysphagia, 31(1), 39-49.
Buyon JP, Kim MY, Guerra MM, Laskin CA, Petri M, Lockshin MD, Sammaritano L, Branch DW, Porter TF, Sawitzke A, Merrill JT, Stephenson MD, Cohn E, Garabet L, Salmon JE (2015). Predictors of Pregnancy Outcomes in Patients With Lupus: A Cohort Study. Ann Intern Med, 163(3), 153-63.
Jones BB, Millsop JW, Walsh JA, Krueger GG, Callis Duffin K (2015). Onset of psoriatic arthritis during ustekinumab treatment for psoriasis: a case series of seven patients. Br J Dermatol, 173(1), 272-4.
Saxena R, Georgopoulos NA, Braaten TJ, Bjonnes AC, Koika V, Panidis D, Welt CK (2015). Han Chinese polycystic ovary syndrome risk variants in women of European ancestry: relationship to FSH levels and glucose tolerance. Hum Reprod, 30(6), 1454-9.
Roy N, Tanner K, Merrill RM, Wright C, Miller KL, Kendall KA (Spring 2015). Descriptive Epidemiology of Voice Disorders in Rheumatoid Arthritis: Prevalence, Risk Factors, and Quality of Life Burden. J Voice, 30(1), 74-87.
Tanner K, Pierce JL, Merrill RM, Miller KL, Kendall KA, Roy N (Spring 2015). The Quality of Life Burden Associated With Voice Disorders in Sjögren's Syndrome. Ann Otol Rhinol Laryngol, 124(9), 721-27.
Carmona FD, Mackie SL, Martn JE, Taylor JC, Vaglio A, Eyre S, Bossini-Castillo L, Castaeda S, Cid MC, Hernndez-Rodrguez J, Prieto-Gonzlez S, Solans R, Ramentol-Sintas M, Gonzlez-Escribano MF, Ortiz-Fernndez L, Morado IC, Narvez J, Miranda-Filloy JA, Spanish GCA Group, Beretta L, Lunardi C, Cimmino MA, Gianfreda D, Santilli D, Ramirez GA, Soriano A, Muratore F, Pazzola G, Addimanda O, Wijmenga C, Witte T, Schirmer JH, Moosig F, Schnau V, Franke A, Palm, Molberg, Diamantopoulos AP, Carette S, Cuthbertson D, Forbess LJ, Hoffman GS, Khalidi NA, Koening CL, Langford CA, McAlear CA, Moreland L, Monach PA, Pagnoux C, Seo P, Spiera R, Sreih AG, Warrington KJ, Ytterberg SR, Gregersen PK, Pease CT, Gough A, Green M, Hordon L, Jarrett S, Watts R, Levy S, Patel Y, Kamath S, Dasgupta B, Worthington J, Koeleman BP, de Bakker PI, Barrett JH, Salvarani C, Merkel PA, Gonzlez-Gay MA, Morgan AW, Martn J (2015). A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility. Am J Hum Genet, 96(4), 565-80.
Walsh JA, Zhou X, Clegg DO, Teng C, Cannon GW, Sauer B (2015). Mortality in American Veterans with the HLA-B27 gene. J Rheumatol, 42(4), 638-44.
Tanner K, Nissen SL, Merrill RM, Miner A, Channell RW, Miller KL, Elstad M, Kendall KA, Roy N (Spring 2015). Nebulized Isotonic Saline Improves Voice Production in Sjogrens Syndrome. Laryngoscope.
Sieper J, Landew R, Rudwaleit M, van der Heijde D, Dougados M, Mease PJ, Braun J, Deodhar A, Kivitz A, Walsh J, Hoepken B, Nurminen T, Maksymowych WP (2014). Effect of certolizumab pegol over ninety-six weeks in patients with axial spondyloarthritis: results from a phase III randomized trial. Arthritis Rheumatol, 67(3), 668-77.
Frech TM, Pimentel R, Mineau G, Sawitzke A, Penmetsa G, Wong J (2015). Parental influence on systemic sclerosis. Arthritis Care Res (Hoboken), 67(2), 310-2.
Miller KL, Grotzke MP, Lawrence P, Rosenblum Y, Nelson R, Lafleur J, Cannon GW (2015). Implementation of a Bone Health Team Markedly Improves Osteoporosis Screening, Diagnosis and Treatment Initiation Rates Compared to Standard Primary Care Practice [Abstract].
Coates LC, Walsh J, Haroon M, FitzGerald O, Aslam T, Al Balushi F, Burden AD, Burden-Teh E, Caperon AR, Cerio R, Chattopadhyay C, Chinoy H, Goodfield MJ, Kay L, Kelly S, Kirkham BW, Lovell CR, Marzo-Ortega H, McHugh N, Murphy R, Reynolds NJ, Smith CH, Stewart EJ, Warren RB, Waxman R, Wilson HE, Helliwell PS (2013). Development and testing of new candidate psoriatic arthritis screening questionnaires combining optimal questions from existing tools. Arthritis Care Res (Hoboken), 66(9), 1410-6.
Walsh JA, McFadden ML, Morgan MD, Sawitzke AD, Duffin KC, Krueger GG, Clegg DO (2014). Work productivity loss and fatigue in psoriatic arthritis. J Rheumatol, 41(8), 1670-4.
Heller A, Tanner K, Roy N, Nissen SL, Merrill RM, Miller KL, Houtz DR, Ellerston J, Kendall K (2014). Voice, Speech, and Laryngeal Features of Primary Sjögren's Syndrome. Ann Otol Rhinol Laryngol, 123(778).
Boehncke WH, Qureshi A, Merola JF, Thai D, Krueger GG, Walsh J, Kim N, Gottlieb AB (2013). Diagnosing and treating psoriatic arthritis: an update. Br J Dermatol, 170(4), 772-86.
Goldberg A, Geppert T, Schiopu E, Frech T, Hsu V, Simms RW, Peng SL, Yao Y, Elgeioushi N, Chang L, Wang B, Yoo S (2014). Dose-escalation of human anti-interferon-alpha receptor monoclonal antibody MEDI-546 in subjects with systemic sclerosis: a phase 1, multicenter, open label study. Arthritis Res Ther, 16(1), R57.
Kinard K, Walsh JA, Penmetsa GK, Warner JE (2014). Adalimumab and Non-Arteritic Anterior Ischaemic Optic Neuropathy: A Case Report. Neuro Ophthalmol, 38(5), 272-277.
Pierce JL, Tanner K, PhD, Merrill RM, Miller KL, Ambati BK, Kendall KA, Roy N (2014). Voice Disorders in Sjogrens Syndrome: Prevalence and Related Risk Factors. Laryngoscope.
Zhang M, Staes C, Kapp L, Miller KL (2014). Best Practices for Best Practice Alerts: Evaluation of a Best Practice Alert to Detect Chronic Glucocorticoid Use. [Abstract]. Arthritis and Rheumatism, 66(11), S1009.
Walsh JA, McFadden M, Woodcock J, Clegg DO, Helliwell P, Dommasch E, Gelfand JM, Krueger GG, Duffin KC (2013). Product of the Physician Global Assessment and body surface area: a simple static measure of psoriasis severity in a longitudinal cohort. J Am Acad Dermatol, 69(6), 931-7.
Grayson PC, Cuthbertson D, Carette S, Hoffman GS, Khalidi NA, Koening CL, Langford CA, Maksimowicz-McKinnon K, Monach PA, Seo P, Specks U, Ytterberg SR, Merkel PA, Vasculitis Clinical Research Consortium (2013). New features of disease after diagnosis in 6 forms of systemic vasculitis. J Rheumatol, 40(11), 1905-12.
Helliwell PS, FitzGerald O, Fransen J, Gladman DD, Kreuger GG, Callis-Duffin K, McHugh N, Mease PJ, Strand V, Waxman R, Azevedo VF, Beltran Ostos A, Carneiro S, Cauli A, Espinoza LR, Flynn JA, Hassan N, Healy P, Kerzberg EM, Lee YJ, Lubrano E, Marchesoni A, Marzo-Ortega H, Porru G, Moreta EG, Nash P, Raffayova H, Ranza R, Raychaudhuri SP, Roussou E, Scarpa R, Song YW, Soriano ER, Tak PP, Ujfalussy I, de Vlam K, Walsh JA (2012). The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project). Ann Rheum Dis, 72(6), 986-91.
Frech TM, Smith G, Reily M, Chamberlain J, Murtaugh MA, Penrod J, Battistone MJ, Stults BM (2013). Peripheral neuropathy: a complication of systemic sclerosis. Clin Rheumatol, 32(6), 885-8.
Tanner K, Roy N, Merrill RM, Kendall K, Miller KL, Clegg DO, Heller A, Houtz DR, Elstad M (Published). Comparing nebulized water versus saline after laryngeal desiccation challenge in Sjogren’s Syndrome. Laryngoscope.
Walsh JA, Callis Duffin K, Krueger GG, Clegg DO (2013). Limitations in screening instruments for psoriatic arthritis: a comparison of instruments in patients with psoriasis. J Rheumatol, 40(3), 287-93.
Koening CL (2012). New concepts in the pathogenesis and treatment of vasculitis syndromes. Curr Opin Rheumatol, 25(1), 2.
Garvin HM, Passalacqua NV, Uhl NM, Gipson DR, Overbury RS, Cabo LL (2012). Developments in Forensic Anthropology: Age-at-Death Estimation. In Dirkmaat DC (Ed.), A Companion to Forensic Anthropology (10, pp. 202-223). Chichester, UK: John Wiley and Sons.
Hernndez-Rodrguez J, Tan CD, Koening CL, Khasnis A, Rodrguez ER, Hoffman GS (2012). Testicular vasculitis: findings differentiating isolated disease from systemic disease in 72 patients. Medicine (Baltimore), 91(2), 75-85.
Frech TM, Penrod J, Battistone MJ, Sawitzke AD, Stults BM (2012). The prevalence and clinical correlates of an auscultatory gap in systemic sclerosis patients. Int J Rheumatol, 2012, 590845.
Arteta-Bulos R, Miller PJE, Overbury RS, Schwartzberg A, Walker MS, Schwartzberg LS (2012). Prognostic significance of circulating tumor cell (CTC) levels at various times during first-and second-line chemotherapy for metastatic breast cancer [Abstract]. Journal of Clinical Oncology, 30, e21077.
Karla L Miller, Tracy M Frech, Tom Greene, Khe-ni Ma, Molly McFadden, Lillian Tom-Orme, Laurie J Moyer-Mileur, Martha Slattery and Maureen Murtaugh University of Utah School of Medicine, SLC, UT (11/07/2011). Bone Mineral Density Across Age and Gender in Navajo People Com- pared to the National Health and Nutrition Examination Surveys III: the Education and Research Toward Health Study. [Abstract]. Arthritis & Rheumatism, 63(10 (Supplement)), S355-356.
Karla L Miller, Tracy M Frech, Tom Greene, Khe-ni Ma, Molly McFadden, Lillian Tom- Orme, Laurie J Moyer-Mileur, Martha Slattery and Maureen Murtaugh University of Utah School of Medicine, SLC, UT (11/07/2011). Prevalence of Low Bone Mass and Osteoporosis in Navajo People Older Than 50 Across Age, Gender, and Body Mass Index. [Abstract]. Arthritis & Rheumatism, 63(10 (Supplement)), S355-356.
Miller KL, Clegg DO (02/01/2011). Glucosamine and Chondroitin Sulfate. Rheum Dis Clin North Am.
Miller KL, Clegg DO (2010). Glucosamine and chondroitin sulfate. Rheum Dis Clin North Am, 37(1), 103-18.
Lebiedz-Odrobina D, Kay J (2010). Rheumatic manifestations of diabetes mellitus. [Review]. Rheum Dis Clin North Am, 36(4), 681-99.
Miller KL, Clegg DO (07/2010). Chondroitin. In Paul Coates; Marc R. Blackman; Gordon Cragg; Mark Levine; Joel Moss; Jeffery White (Ed.), Encyclopedia of Dietary Supplements (2nd Edition). Informa Healthcare.
De Domenico I, Zhang TY, Koening CL, Branch RW, London N, Lo E, Daynes RA, Kushner JP, Li D, Ward DM, Kaplan J (2010). Hepcidin mediates transcriptional changes that modulate acute cytokine-induced inflammatory responses in mice. J Clin Invest, 120(7), 2395-405.
Miller KL, Clegg D (07/2010). Glucosamine. In Paul Coates; Marc R. Blackman; Gordon Cragg; Mark Levine; Joel Moss; Jeffery White (Ed.), Encyclopedia of Dietary Supplements (Second Edition). Informa Healthcare.
Aggarwal R, Lebiedz-Odrobina D, Sinha A, Manadan A, Case JP (2009). Serum cardiac troponin T, but not troponin I, is elevated in idiopathic inflammatory myopathies. J Rheumatol, 36(12), 2711-4.
Koening CL, Mu HH, Van Schelt A, Lo E, Ward DM, Kaplan J, De Domenico I (2009). Hepcidin is elevated in mice injected with Mycoplasma arthritidis. J Inflamm, 6, 33.
Miller KL, Cannon GW (2009). Management of Sarcoidosis, Behcet's Disease, and other rare rheumatic diseases. In Michael H. Weisman, Michael E. Weinblatt, James S. Louie, Ronald F. Van Vollenhoven (Eds.), Targeted Treatment of the Rheumatic Diseases (First Edition, pp. 238-248). Philadelphia: Saunders, W.B.
Magrey MN, Villa-Forte A, Koening CL, Myles JL, Hoffman GS (2009). Persistent hematuria after induction of remission in Wegener granulomatosis: a therapeutic dilemma. Medicine (Baltimore), 88(6), 315-321.
Koening CL, Miller JC, Nelson JM, Ward DM, Kushner JP, Bockenstedt LK, Weis JJ, Kaplan J, De Domenico I (2009). Toll-like receptors mediate induction of hepcidin in mice infected with Borrelia burgdorferi. Blood, 114(9), 1913-8.
Overbury RS, Cabo LL, Dirkmaat DC, Symes SA (2009). Asymmetry of the os pubis: implications for the Suchey-Brooks method. Am J Phys Anthropol, 139(2), 261-8.
Miller KL, Sawitzke AD, Doane J (2008). Abatacept and serious respiratory infections in patients with previous lung disease. Clin Rheumatol, 27(12), 1569-71.
Miller KL, Sawitzke AD, Doane J (2008). Abatacept and serious respiratory infections in patients with previous lung disease. Clin Rheumatol.
Koening CL, Langford CA (2008). Takayasu's arteritis. Curr Treat Options Cardiovasc Med, 10(2), 164-72.
Miller KL, Sawitzke AD (2007). Performance of Selected Tests for RA in the Utah Clinical Population. [Abstract]. American College of Rheumatology Program Book Supplement: Late-breaking and fellows-in-training abstracts, (2007), 47.
Frech T, Coffin C, Bohnsack JF, Prahalad S (2006). Concurrent occurrence of eosinophilic fasciitis and morphea in two children. Pediatr Rheumatol Online J, 4(1).
Sawitzke A, Joyner D, Knudtson K, Mu HH, Cole B (2000). Anti-MAM antibodies in rheumatic disease: evidence for a MAM-like superantigen in rheumatoid arthritis? J Rheumatol, 27(2), 358-64.
Zamboni WC, Houghton PJ, Hulstein JL, Kirstein M, Walsh J, Cheshire PJ, Hanna SK, Danks MK, Stewart CF (1999). Relationship between tumor extracellular fluid exposure to topotecan and tumor response in human neuroblastoma xenograft and cell lines. Cancer Chemother Pharmacol, 43(4), 269-76.
Tomie A, Cunha C, Thomas J, Benjamin D, Pohorecky L (1997). Effects of A Autoshaping Procedures on Monoamine Levels in Rats. Society For Neuroscience Abstracts, Society for Neuroscience, 23(1-2), 1857.